Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Green

Showing results (31-40 of 285) with videos related to

Pageof 29
Sort By:
Retina (Philadelphia, Pa.)|July 29, 2005
Age-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman Lecture. 1992W Richard Green, Cheryl Enger
Current Drug Targets. CNS and Neurological Disorders|April 29, 2005
Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengersA Richard Green, Tim Ashwood
Acta Cytologica|February 19, 2004
Significance of spindle-shaped and stellate cells in filter preparations of vitreous aspiratesGregor Wollensak, William Richard Green
British Journal of Clinical Pharmacology|February 25, 2012
From basic to clinical neuropharmacology: targetophilia or pharmacodynamics?A Richard Green, Jeffrey K Aronson
British Journal of Clinical Pharmacology|June 4, 2019
The British Pharmacological Society's WDM Paton Memorial Lecture 2019: How doctors were informed about pharmaceutical products through advertising in the British Medical Journal from 1955/6 to 1985/6Jeffrey K Aronson, A Richard Green
BMJ Case Reports|January 3, 2023
Primary nasopharyngeal tuberculosisRasads Misirovs, Lisa Johnston, Richard Green
Journal of Psychopharmacology (Oxford, England)|March 29, 2014
Pharmacology should be at the centre of all preclinical and clinical studies on new psychoactive substances (recreational drugs)A Richard Green, David J Nutt
American Journal of Ophthalmology|March 12, 2004
Choroidal neovascularizationHans E Grossniklaus, W Richard Green
ACS Chemical Neuroscience|January 22, 2013
How do we re-engage the pharmaceutical industry in research on serotonin and psychiatric disorders?A Richard Green, Charles A Marsden
BMJ Case Reports|December 21, 2023
Particulate synovitis granuloma complication following a first metatarsophalangeal joint silastic implantDerek Protheroe, Richard Green, Mark Hayes
Pageof 29

Showing results (31-40 of 285) with videos related to

Sort By:
Pageof 29
Retina (Philadelphia, Pa.)|July 29, 2005
Age-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman Lecture. 1992W Richard Green, Cheryl Enger
Current Drug Targets. CNS and Neurological Disorders|April 29, 2005
Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengersA Richard Green, Tim Ashwood
Acta Cytologica|February 19, 2004
Significance of spindle-shaped and stellate cells in filter preparations of vitreous aspiratesGregor Wollensak, William Richard Green
British Journal of Clinical Pharmacology|February 25, 2012
From basic to clinical neuropharmacology: targetophilia or pharmacodynamics?A Richard Green, Jeffrey K Aronson
British Journal of Clinical Pharmacology|June 4, 2019
The British Pharmacological Society's WDM Paton Memorial Lecture 2019: How doctors were informed about pharmaceutical products through advertising in the British Medical Journal from 1955/6 to 1985/6Jeffrey K Aronson, A Richard Green
BMJ Case Reports|January 3, 2023
Primary nasopharyngeal tuberculosisRasads Misirovs, Lisa Johnston, Richard Green
Journal of Psychopharmacology (Oxford, England)|March 29, 2014
Pharmacology should be at the centre of all preclinical and clinical studies on new psychoactive substances (recreational drugs)A Richard Green, David J Nutt
American Journal of Ophthalmology|March 12, 2004
Choroidal neovascularizationHans E Grossniklaus, W Richard Green
ACS Chemical Neuroscience|January 22, 2013
How do we re-engage the pharmaceutical industry in research on serotonin and psychiatric disorders?A Richard Green, Charles A Marsden
BMJ Case Reports|December 21, 2023
Particulate synovitis granuloma complication following a first metatarsophalangeal joint silastic implantDerek Protheroe, Richard Green, Mark Hayes
Pageof 29